Primary Open-angle Glaucoma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Mar 22, 2018

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • LX7101 (0.125%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Aug 31, 2015